Cite
HARVARD Citation
Cornblath, D. et al. (2018). A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Journal of the peripheral nervous system. 23 (2), pp. 108-114. [Online].